Drug Delivery Polymer Market - Forecasts from 2018 to 2023

Drug Delivery Polymer Market - Forecasts from 2018 to 2023

The drug delivery polymer market is projected to grow at a CAGR of XX.XX% to reach US$XX.XXX billion by 2023, from US$XX.XXX billion in 2017. Polymers used for the delivery of drugs into an animal during pre-clinical and humans during clinical trials (for the study of drug dynamics) and also during the medical procedures or after the procedure is over are known as Drug Delivery Polymers. They act as a carrier for the controlled release of drugs into the body. Therefore, they find immense potential in healthcare and pharmaceuticals. On the basis of their characteristics which include natural or synthetic or combination of both, protein-based, polyester etc., degradable or non-biodegradable and hydrophilic or hydrophobic these polymers are inert drug carriers and thus are considered safe for consumption.

Switzerland, from the European region, has the highest production of pharmaceuticals. The multinational corporations, Roche and Novartis have their headquarters in Basel. Furthermore, the growing healthcare expenditure, increasing elderly population worldwide and a worldwide prevalence of chronic diseases are some of the drivers driving the market growth.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the drug delivery polymer value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the drug delivery polymer market.

Major industry players profiled as part of the report are AdhexPharma, Polymer Therapeutics, LLC, Bezwada Biomedical, LLC., POLYVATION BV and Poly-Med, Inc. among others.

Segmentation

The drug delivery polymer market has been analyzed through following segments:

By Material Type

PLGA (Polylactic-co-glycolic acid)

PGA (Poly-l-glutamic acid)

Polylactic acid (Biodegradable)

Temperature responsive polymer

Organic polymer

Others


By Drug Delivery Application

Diffusion-controlled

Solvent activated

Biodegradable or Chemically controlled

Externally triggered (i.e. pH, temperature etc.)


By End User

Academic and Research Institutes

Hospitals

Pharmaceutical Companies


By Geography

North America

USA

Canada

Mexico

Others


South America

Brazil

Argentina

Others


Europe

Germany

France

United Kingdom

Spain

Others


Middle East and Africa

Saudi Arabia

Israel

Others


Asia Pacific

China

Japan

South Korea

India

Others


Target audience

Manufacturers

Suppliers

Distributors

Service Providers

Government Agencies

Research Organizations

Consultants


Key insights offered

What will be the drug delivery polymer market size from 2017 to 2023?

How are the major drivers and restraints affecting the drug delivery polymer market growth and the opportunities which exist for key vendors?

Which segment and region will drive or lead the market growth and why?

A comprehensive analysis of competitive landscape and key market participants’ behaviour

Key strategies being adopted by vendors, with in-depth analysis along with their impact on competition and market growth.

1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY  
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Force Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. DRUG DELIVERY POLYMER MARKET BY MATERIAL TYPE
5.1. PLGA (Polylactic-co-glycolic acid)
5.2. PGA (Poly-l-glutamic acid)
5.3. Polylactic acid (Biodegradable)
5.4. Temperature responsive polymer 
5.5. Organic polymer 
5.6. Others
6. DRUG DELIVERY POLYMER MARKET BY DRUG DELIVERY APPLICATION
6.1. Diffusion-controlled
6.2. Solvent activated
6.3. Biodegradable or Chemically controlled
6.4. Externally triggered (i.e. pH, temperature etc.)
7. DRUG DELIVERY POLYMER MARKET BY END USER
7.1. Academic and Research Institutes
7.2. Hospitals
7.3. Pharmaceutical Companies
8. DRUG DELIVERY POLYMER MARKET BY GEOGRAPHY
8.1. North America
8.1.1. USA
8.1.2. Canada
8.1.3. Mexico
8.1.4. Others
8.2. South America
8.2.1. Brazil
8.2.2. Argentia
8.2.3. Others
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. United Kingdom
8.3.4. Spain
8.3.5. Others
8.4. Middle East and Africa
8.4.1. Saudi Arabia
8.4.2. Israel
8.4.3. Others
8.5. Asia Pacific
8.5.1. China
8.5.2. Japan
8.5.3. South Korea
8.5.4. India
8.5.5. Others
9. COMPETITIVE INTELLIGENCE
9.1.  Market Share of Key Players
9.2.  Recent Investment and Deals
9.3. Strategies of Key Players
10. COMPANY PROFILES
10.1. AdhexPharma
10.1.1. Company Overview
10.1.2. Financials
10.1.3. Products and Services
10.1.4. Recent Developments
10.2. Polymer Therapeutics, LLC
10.2.1. Company Overview
10.2.2. Financials
10.2.3. Products and Services
10.2.4. Recent Developments
10.3.  Bezwada Biomedical, LLC.
10.3.1. Company Overview
10.3.2. Financials
10.3.3. Products and Services
10.3.4. Recent Developments
10.4. POLYVATION BV
10.4.1. Company Overview
10.4.2. Financials
10.4.3. Products and Services
10.4.4. Recent Developments
10.5.  Poly-Med, Inc.
10.5.1. Company Overview
10.5.2. Financials
10.5.3. Products and Services
10.5.4. Recent Developments
10.6. Henkel Corporation
10.6.1. Company Overview
10.6.2. Financials
10.6.3. Products and Services
10.6.4. Recent Developments
10.7. Evonik Industries AG
10.7.1. Company Overview
10.7.2. Financials
10.7.3. Products and Services
10.7.4. Recent Developments
10.8. ULTROXA® Polymers
10.8.1. Company Overview
10.8.2. Financials
10.8.3. Products and Services
10.8.4. Recent Developments
10.9. Serina Therapeutics
10.9.1. Company Overview
10.9.2. Financials
10.9.3. Products and Services
10.9.4. Recent Developments
10.10. The Lubrizol Corporation
10.10.1. Company Overview
10.10.2. Financials
10.10.3. Products and Services
10.10.4. Recent Developments
LIST OF FIGURES
LIST OF TABLES
DISCLAIMER 

AdhexPharma

Polymer Therapeutics, LLC

Bezwada Biomedical, LLC.

POLYVATION BV

Poly-Med, Inc.

Henkel Corporation

Evonik Industries AG

ULTROXA® Polymers

Serina Therapeutics

The Lubrizol Corporation

  • SKU:
  • Publishing Date: 2018-12-05
  • Product Code: 1
  • Availability: In Stock
  • $3,800.00
  • Ex Tax: $3,800.00

Available Options